Detalhe da pesquisa
1.
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
Blood
; 143(12): 1139-1156, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38064663
2.
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study.
Blood
; 143(8): 673-684, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883795
3.
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.
Blood
; 141(6): 634-644, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219880
4.
Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes.
Blood
; 141(6): 645-658, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223592
5.
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
Blood
; 141(5): 534-549, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322930
6.
Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing.
Br J Haematol
; 204(3): 910-920, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098188
7.
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Blood
; 139(8): 1198-1207, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34469514
8.
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy.
Blood
; 140(20): 2127-2141, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35709339
9.
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Blood
; 139(24): 3519-3531, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192684
10.
Systemic diffuse large B-cell lymphoma involving the central nervous system have high rates of defective antigen presentation and immune surveillance.
Haematologica
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511272
11.
Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia.
Br J Haematol
; 202(4): 760-770, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052611
12.
Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cells.
Blood
; 138(16): 1391-1405, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974080
13.
Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma.
Curr Treat Options Oncol
; 24(8): 929-947, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249800
14.
Targeting the BRAF pathway in haematological diseases.
Intern Med J
; 53(5): 845-849, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222093
15.
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax.
Blood
; 135(25): 2266-2270, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32244251
16.
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review.
Eur J Haematol
; 108(6): 469-485, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158410
17.
VEXAS syndrome: A dermatological perspective.
Australas J Dermatol
; 63(4): 488-492, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197697
18.
Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target.
Br J Haematol
; 195(1): 113-118, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34426978
19.
Proliferative Glomerulonephritis With Fibrils, Monoclonal κ Light Chain, and C3 Deposits.
Am J Kidney Dis
; 78(3): 459-463, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33774080
20.
Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
Haematologica
; 106(1): 64-73, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054657